From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax

Introduction: Numerous challenges have hampered developing an anti-malarial vaccine against the most widespread malarial parasite worldwide: Plasmodium vivax. Despite the progress achieved in studying proteins in short-term in vitro culture or in experimental models, there is still no clear method f...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24050
Acceso en línea:
https://doi.org/10.1080/14760584.2020.1733421
https://repository.urosario.edu.co/handle/10336/24050
Palabra clave:
Epitope
Protozoal protein
Protozoal vaccine
Antigenicity
Cell interaction
Dna polymorphism
Jk-1 cell line
Nonhuman
Plasmodium vivax
Platyrrhini
Priority journal
Protein function
Protein interaction
Reticulocyte
Reverse genetics
Review
In vitro culture
Malaria
Plasmodium vivax
Protective immune response
Receptor-ligand interaction
Vaccine
Rights
License
Abierto (Texto Completo)
id EDOCUR2_fae33d0d2eaa2a1c2f14c53a034e8cf6
oai_identifier_str oai:repository.urosario.edu.co:10336/24050
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 79653065600eca483d3-a229-42c8-8a6d-3b5e6f002e5b-14138d92d-a7e8-46a5-b415-2d76a4bb9f23-12020-05-26T00:08:02Z2020-05-26T00:08:02Z2020Introduction: Numerous challenges have hampered developing an anti-malarial vaccine against the most widespread malarial parasite worldwide: Plasmodium vivax. Despite the progress achieved in studying proteins in short-term in vitro culture or in experimental models, there is still no clear method for defining which antigens or their regions should be prioritized for including them in a vaccine. Areas covered: The methods used by research groups so far which have focused on the functional analysis of P. vivax blood stage antigens have been reviewed here. A logical strategy orientated toward resolving two of the most commonly occurring problems in designing vaccines against this species has thus been proposed (i.e. the search for candidates and evaluating/ascertaining their functional role in the invasion of such molecules). Expert commentary: Advances in knowledge regarding P. vivax biology have been extremely slow. Only two key receptor–ligand interactions concerning merozoite entry to reticulocytes have been reported during the last 20 years: PvDBP1-DARC and PvRBP2b-CD71. Despite increasing knowledge about the parasite’s intimate preference for its host cells, it has yet to be determined which regions of the merozoite molecules characterized to date meet the requirement of inducing protective immune responses effectively blocking heterologous parasite entry to human cells. © 2020, © 2020 Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/14760584.2020.173342114760584https://repository.urosario.edu.co/handle/10336/24050engTaylor and Francis Ltd207No. 2195Expert Review of VaccinesVol. 19Expert Review of Vaccines, ISSN:14760584, Vol.19, No.2 (2020); pp. 195-207https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080136022&doi=10.1080%2f14760584.2020.1733421&partnerID=40&md5=62d006e8d895475d3936104ab684bee4Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocUREpitopeProtozoal proteinProtozoal vaccineAntigenicityCell interactionDna polymorphismJk-1 cell lineNonhumanPlasmodium vivaxPlatyrrhiniPriority journalProtein functionProtein interactionReticulocyteReverse geneticsReviewIn vitro cultureMalariaPlasmodium vivaxProtective immune responseReceptor-ligand interactionVaccineFrom a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivaxarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Patarroyo, Manuel A.Arévalo-Pinzón, GabrielaMoreno-Pérez, Darwin A10336/24050oai:repository.urosario.edu.co:10336/240502022-05-02 07:37:21.37173https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
title From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
spellingShingle From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
Epitope
Protozoal protein
Protozoal vaccine
Antigenicity
Cell interaction
Dna polymorphism
Jk-1 cell line
Nonhuman
Plasmodium vivax
Platyrrhini
Priority journal
Protein function
Protein interaction
Reticulocyte
Reverse genetics
Review
In vitro culture
Malaria
Plasmodium vivax
Protective immune response
Receptor-ligand interaction
Vaccine
title_short From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
title_full From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
title_fullStr From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
title_full_unstemmed From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
title_sort From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax
dc.subject.keyword.spa.fl_str_mv Epitope
Protozoal protein
Protozoal vaccine
Antigenicity
Cell interaction
Dna polymorphism
Jk-1 cell line
Nonhuman
Plasmodium vivax
Platyrrhini
Priority journal
Protein function
Protein interaction
Reticulocyte
Reverse genetics
Review
In vitro culture
Malaria
Plasmodium vivax
Protective immune response
Receptor-ligand interaction
Vaccine
topic Epitope
Protozoal protein
Protozoal vaccine
Antigenicity
Cell interaction
Dna polymorphism
Jk-1 cell line
Nonhuman
Plasmodium vivax
Platyrrhini
Priority journal
Protein function
Protein interaction
Reticulocyte
Reverse genetics
Review
In vitro culture
Malaria
Plasmodium vivax
Protective immune response
Receptor-ligand interaction
Vaccine
description Introduction: Numerous challenges have hampered developing an anti-malarial vaccine against the most widespread malarial parasite worldwide: Plasmodium vivax. Despite the progress achieved in studying proteins in short-term in vitro culture or in experimental models, there is still no clear method for defining which antigens or their regions should be prioritized for including them in a vaccine. Areas covered: The methods used by research groups so far which have focused on the functional analysis of P. vivax blood stage antigens have been reviewed here. A logical strategy orientated toward resolving two of the most commonly occurring problems in designing vaccines against this species has thus been proposed (i.e. the search for candidates and evaluating/ascertaining their functional role in the invasion of such molecules). Expert commentary: Advances in knowledge regarding P. vivax biology have been extremely slow. Only two key receptor–ligand interactions concerning merozoite entry to reticulocytes have been reported during the last 20 years: PvDBP1-DARC and PvRBP2b-CD71. Despite increasing knowledge about the parasite’s intimate preference for its host cells, it has yet to be determined which regions of the merozoite molecules characterized to date meet the requirement of inducing protective immune responses effectively blocking heterologous parasite entry to human cells. © 2020, © 2020 Informa UK Limited, trading as Taylor and Francis Group.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:08:02Z
dc.date.available.none.fl_str_mv 2020-05-26T00:08:02Z
dc.date.created.spa.fl_str_mv 2020
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1080/14760584.2020.1733421
dc.identifier.issn.none.fl_str_mv 14760584
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24050
url https://doi.org/10.1080/14760584.2020.1733421
https://repository.urosario.edu.co/handle/10336/24050
identifier_str_mv 14760584
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 207
dc.relation.citationIssue.none.fl_str_mv No. 2
dc.relation.citationStartPage.none.fl_str_mv 195
dc.relation.citationTitle.none.fl_str_mv Expert Review of Vaccines
dc.relation.citationVolume.none.fl_str_mv Vol. 19
dc.relation.ispartof.spa.fl_str_mv Expert Review of Vaccines, ISSN:14760584, Vol.19, No.2 (2020); pp. 195-207
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080136022&doi=10.1080%2f14760584.2020.1733421&partnerID=40&md5=62d006e8d895475d3936104ab684bee4
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Taylor and Francis Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167459883646976